18F-mFBG Expression in Neural Crest Tumors and Organs Innervated by the Sympathetic Nervous System
Status:
WITHDRAWN
Trial end date:
2025-12-01
Target enrollment:
Participant gender:
Summary
This is a prospective Phase 2 study being performed to document the relationship between 18F-mIBG positron emission tomography (PET) findings in subjects, and expression of the norepinephrine transporter. In addition to collecting safety data for the imaging agent, the study aims to:
* compare the findings against other catacholamine transporters
* evaluate the imaging results at different time points and in different organs
* assess the quality of images with lower doses
* compare the ability to detect neuroblastoma lesions against other imaging agents, and in other tumors